Search
Becton Dickinson and Co
BDXAdd to Watchlist
143.980USD
+2.350+1.66%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
39.67BMarket Cap
36.27P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Becton Dickinson and Co is 7.22, ranking 148 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 201.92, with a high of 265.34 and a low of 183.00.
Analyst Rating
Based on
17
analysts
Buy
Current Rating
183.436
Target Price
+27.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Becton Dickinson and Co
BDX
17
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Becton Dickinson and Co's expected revenue for the next quarter?
Becton Dickinson and Co's expected revenue is 4.88B.
What is Becton Dickinson and Co's price target?
Analysts forecast that Becton Dickinson and Co's price target is USD 201.92, with the highest forecast at USD 265.34 and the lowest forecast at USD 183.00.
How have Becton Dickinson and CoBDX's recent earnings per share performed?
The market expectation was USD -1.11, while Becton Dickinson and CoBDX's earnings per share (EPS) for the previous quarter was USD 1.34. EPS for the next quarter is expected at USD 3.13.
What is the analyst rating for Becton Dickinson and Co?
Based on the ratings of Becton Dickinson and Co's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
